JP4532602B2 - 皮膚充填剤組成物 - Google Patents
皮膚充填剤組成物 Download PDFInfo
- Publication number
- JP4532602B2 JP4532602B2 JP2009541209A JP2009541209A JP4532602B2 JP 4532602 B2 JP4532602 B2 JP 4532602B2 JP 2009541209 A JP2009541209 A JP 2009541209A JP 2009541209 A JP2009541209 A JP 2009541209A JP 4532602 B2 JP4532602 B2 JP 4532602B2
- Authority
- JP
- Japan
- Prior art keywords
- skin
- collagen
- pmma
- filler
- volume
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000945 filler Substances 0.000 title claims description 46
- 239000000203 mixture Substances 0.000 title claims description 20
- 230000002500 effect on skin Effects 0.000 title description 10
- 229920003229 poly(methyl methacrylate) Polymers 0.000 claims description 37
- 239000004926 polymethyl methacrylate Substances 0.000 claims description 37
- 229920002307 Dextran Polymers 0.000 claims description 20
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 claims description 16
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 claims description 15
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 claims description 15
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 claims description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 11
- 239000002504 physiological saline solution Substances 0.000 claims description 10
- 239000012153 distilled water Substances 0.000 claims description 9
- 210000003491 skin Anatomy 0.000 description 39
- 229920001436 collagen Polymers 0.000 description 24
- 230000000694 effects Effects 0.000 description 21
- 108010035532 Collagen Proteins 0.000 description 20
- 102000008186 Collagen Human genes 0.000 description 20
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 14
- 229920002674 hyaluronan Polymers 0.000 description 14
- 229960003160 hyaluronic acid Drugs 0.000 description 14
- 239000007924 injection Substances 0.000 description 10
- 238000002347 injection Methods 0.000 description 10
- 210000001519 tissue Anatomy 0.000 description 7
- 206010020751 Hypersensitivity Diseases 0.000 description 5
- 208000030961 allergic reaction Diseases 0.000 description 5
- 210000004207 dermis Anatomy 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 4
- 210000003899 penis Anatomy 0.000 description 4
- 210000004872 soft tissue Anatomy 0.000 description 4
- 238000001356 surgical procedure Methods 0.000 description 4
- 241000283690 Bos taurus Species 0.000 description 3
- 229920005654 Sephadex Polymers 0.000 description 3
- 239000012507 Sephadex™ Substances 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- BFSVOASYOCHEOV-UHFFFAOYSA-N 2-diethylaminoethanol Chemical compound CCN(CC)CCO BFSVOASYOCHEOV-UHFFFAOYSA-N 0.000 description 2
- 208000005422 Foreign-Body reaction Diseases 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 239000004372 Polyvinyl alcohol Substances 0.000 description 2
- 210000000577 adipose tissue Anatomy 0.000 description 2
- 238000009395 breeding Methods 0.000 description 2
- 230000001488 breeding effect Effects 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 210000002540 macrophage Anatomy 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 239000004005 microsphere Substances 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 229920002451 polyvinyl alcohol Polymers 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 230000037303 wrinkles Effects 0.000 description 2
- RWIUTHWKQHRQNP-ZDVGBALWSA-N (9e,12e)-n-(1-phenylethyl)octadeca-9,12-dienamide Chemical compound CCCCC\C=C\C\C=C\CCCCCCCC(=O)NC(C)C1=CC=CC=C1 RWIUTHWKQHRQNP-ZDVGBALWSA-N 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 108010056543 CosmoDerm Proteins 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 229920001954 Restylane Polymers 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 229920001222 biopolymer Polymers 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 239000000501 collagen implant Substances 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 210000002744 extracellular matrix Anatomy 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 230000004761 fibrosis Effects 0.000 description 1
- 239000012847 fine chemical Substances 0.000 description 1
- 108010020199 glutaraldehyde-cross-linked collagen Proteins 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/10—Hair or skin implants
- A61F2/105—Skin implants, e.g. artificial skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/26—Mixtures of macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/26—Penis implants
Landscapes
- Health & Medical Sciences (AREA)
- Transplantation (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Oral & Maxillofacial Surgery (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Engineering & Computer Science (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Reproductive Health (AREA)
- Materials For Medical Uses (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Description
一方、皮膚組織と類似の成分であって、皮膚組織に挿入して軟部組織を拡張させることにより皺の改善や輪郭の矯正などに使われる物質を、一般に皮膚充填剤(dermal filler)またはフィラー(filler)と呼ぶ。このような皮膚充填剤は、作用メカニズムによって次の2タイプに分類できる。一つのタイプは、直接体積を増加させて拡大効果を出す皮膚充填剤である。このような皮膚充填剤の主要成分はコラーゲンやヒアルロン酸などの物質からなっている。もう一つのタイプは、架橋デキストランのように直接体積を増加させる作用を一部行うと同時に、一定の期間以上異物反応を起して長期間または永久的に自己コラーゲン形成を誘導して拡大効果を出す皮膚充填剤である。一方、2タイプの作用メカニズムを全て持っている物質としては、ポリメチルメタクリレート(PMMA)が知られている。
また、本発明の他の観点によれば、ポリメチルメタクリレート(PMMA)と架橋デキストランが1:0.25〜10の体積比で配合された混合物20〜70体積%と、生理食塩水または蒸留水30〜80体積%とを含有し、ポリメチルメタクリレート(PMMA)、架橋デキストラン、および生理食塩水または蒸留水からなる混合物1cc当り5〜40mgのヒドロキシプロピルメチルセルロース(HPMC)を添加してなることを特徴とする、皮膚充填剤組成物を提供する。
Claims (1)
- ポリメチルメタクリレート(PMMA)、架橋デキストラン、ヒドロキシプロピルメチルセルロース(HPMC)、および生理食塩水または蒸留水を含んでおり、前記ポリメチルメタクリレート(PMMA)と前記架橋デキストランが1:0.25〜10の体積比で配合された混合物20〜70体積%と、前記生理食塩水または前記蒸留水30〜80体積%とを含有し、前記ポリメチルメタクリレート(PMMA)、前記架橋デキストラン、および前記生理食塩水または前記蒸留水からなる混合物1cc当り5〜40mgの前記ヒドロキシプロピルメチルセルロース(HPMC)を添加してなることを特徴とする、皮膚充填剤組成物。
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020060126815A KR100759091B1 (ko) | 2006-12-13 | 2006-12-13 | 피부 충전제 조성물 |
PCT/KR2007/005507 WO2008072839A1 (en) | 2006-12-13 | 2007-11-02 | Dermal filler composition |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2010512830A JP2010512830A (ja) | 2010-04-30 |
JP4532602B2 true JP4532602B2 (ja) | 2010-08-25 |
Family
ID=38737979
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2009541209A Active JP4532602B2 (ja) | 2006-12-13 | 2007-11-02 | 皮膚充填剤組成物 |
Country Status (8)
Country | Link |
---|---|
US (1) | US20080279806A1 (ja) |
JP (1) | JP4532602B2 (ja) |
KR (1) | KR100759091B1 (ja) |
CN (2) | CN101199871A (ja) |
HK (1) | HK1128611A1 (ja) |
MY (1) | MY153641A (ja) |
TR (1) | TR200903626T1 (ja) |
WO (1) | WO2008072839A1 (ja) |
Families Citing this family (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2861734B1 (fr) | 2003-04-10 | 2006-04-14 | Corneal Ind | Reticulation de polysaccharides de faible et forte masse moleculaire; preparation d'hydrogels monophasiques injectables; polysaccharides et hydrogels obtenus |
KR100759091B1 (ko) * | 2006-12-13 | 2007-09-17 | 조강선 | 피부 충전제 조성물 |
WO2008147867A2 (en) | 2007-05-23 | 2008-12-04 | Allergan, Inc. | Cross-linked collagen and uses thereof |
US8318695B2 (en) | 2007-07-30 | 2012-11-27 | Allergan, Inc. | Tunably crosslinked polysaccharide compositions |
US8697044B2 (en) * | 2007-10-09 | 2014-04-15 | Allergan, Inc. | Crossed-linked hyaluronic acid and collagen and uses thereof |
PT2818184T (pt) | 2007-11-16 | 2019-01-28 | Aclaris Therapeutics Inc | Composições e métodos para o tratamento de púrpura |
US8394782B2 (en) | 2007-11-30 | 2013-03-12 | Allergan, Inc. | Polysaccharide gel formulation having increased longevity |
US8394784B2 (en) | 2007-11-30 | 2013-03-12 | Allergan, Inc. | Polysaccharide gel formulation having multi-stage bioactive agent delivery |
US8450475B2 (en) | 2008-08-04 | 2013-05-28 | Allergan, Inc. | Hyaluronic acid-based gels including lidocaine |
JP5722217B2 (ja) | 2008-09-02 | 2015-05-20 | アラーガン・ホールディングス・フランス・ソシエテ・パール・アクシオン・サンプリフィエAllergan Holdings France S.A.S. | ヒアルロン酸および/またはその誘導体の糸、その作製方法、ならびにその使用 |
US9114188B2 (en) | 2010-01-13 | 2015-08-25 | Allergan, Industrie, S.A.S. | Stable hydrogel compositions including additives |
US20110172180A1 (en) | 2010-01-13 | 2011-07-14 | Allergan Industrie. Sas | Heat stable hyaluronic acid compositions for dermatological use |
CA2792729C (en) | 2010-03-12 | 2016-06-28 | Allergan Industrie, Sas | Fluid compositions for improving skin conditions |
EP2550027B2 (en) | 2010-03-22 | 2019-03-20 | Allergan, Inc. | Polysaccharide and protein-polysaccharide cross-linked hydrogels for soft tissue augmentation |
KR101003331B1 (ko) | 2010-05-11 | 2010-12-23 | 조강선 | 피부 충전제 조성물 |
US9005605B2 (en) | 2010-08-19 | 2015-04-14 | Allergan, Inc. | Compositions and soft tissue replacement methods |
US8883139B2 (en) | 2010-08-19 | 2014-11-11 | Allergan Inc. | Compositions and soft tissue replacement methods |
US8697057B2 (en) | 2010-08-19 | 2014-04-15 | Allergan, Inc. | Compositions and soft tissue replacement methods |
US8889123B2 (en) | 2010-08-19 | 2014-11-18 | Allergan, Inc. | Compositions and soft tissue replacement methods |
US9408797B2 (en) | 2011-06-03 | 2016-08-09 | Allergan, Inc. | Dermal filler compositions for fine line treatment |
RU2740454C2 (ru) | 2011-06-03 | 2021-01-14 | Аллерган Эндюстри, Сас | Составы кожного наполнителя, включая антиоксиданты |
US20130096081A1 (en) | 2011-06-03 | 2013-04-18 | Allergan, Inc. | Dermal filler compositions |
US9393263B2 (en) | 2011-06-03 | 2016-07-19 | Allergan, Inc. | Dermal filler compositions including antioxidants |
US20130244943A1 (en) | 2011-09-06 | 2013-09-19 | Allergan, Inc. | Hyaluronic acid-collagen matrices for dermal filling and volumizing applications |
US9662422B2 (en) | 2011-09-06 | 2017-05-30 | Allergan, Inc. | Crosslinked hyaluronic acid-collagen gels for improving tissue graft viability and soft tissue augmentation |
EP3620184A1 (en) | 2014-09-30 | 2020-03-11 | Allergan Industrie, SAS | Stable hydrogel compositions including additives |
MX2017009241A (es) | 2015-01-16 | 2018-03-23 | Spineovations Inc | Método de tratamiento de disco intervertebral. |
WO2016128783A1 (en) | 2015-02-09 | 2016-08-18 | Allergan Industrie Sas | Compositions and methods for improving skin appearance |
AU2018203714A1 (en) * | 2017-03-09 | 2018-09-27 | Colin Campbell Marshall Moore | Improved Phalloplasty Method |
CN111558085A (zh) * | 2020-06-16 | 2020-08-21 | 红色未来科技(北京)有限公司 | 一种面部填充剂及其制备方法 |
KR102430642B1 (ko) * | 2020-07-03 | 2022-08-16 | 주식회사 메피온 | 필러 조성물 및 그 제조 방법 |
CN113041397A (zh) * | 2021-04-08 | 2021-06-29 | 红色未来科技(北京)有限公司 | 一种含有交联葡聚糖的面部填充剂及其制备方法 |
CN114225117A (zh) * | 2021-11-08 | 2022-03-25 | 红色未来科技(北京)有限公司 | 一种含有交联葡聚糖的综合性面部填充剂及其制备方法 |
CN114099772A (zh) * | 2021-11-29 | 2022-03-01 | 陕西科美致尚生物科技有限公司 | 一种用于面部塑形填充的材料及其制备方法 |
CN114601967A (zh) * | 2022-04-01 | 2022-06-10 | 上海医妃医药科技有限公司 | 一种含有交联葡聚糖的皮下填充剂 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3841401A1 (de) * | 1988-12-08 | 1990-06-13 | Martin Lemperle | Alloplastisches implantat |
JPH04303445A (ja) * | 1991-03-29 | 1992-10-27 | Nippon Zeon Co Ltd | 創傷被覆材 |
US5397352A (en) * | 1993-08-27 | 1995-03-14 | Burres; Steven | Method of recollagenation |
EP0681845B1 (en) * | 1994-04-11 | 1999-09-22 | Bristol-Myers Squibb Company | Polymer composite implant and method of making the same |
FR2764514B1 (fr) * | 1997-06-13 | 1999-09-03 | Biopharmex Holding Sa | Implant injectable en sous-cutane ou intradermique a bioresorbabilite controlee pour la chirurgie reparatrice ou plastique et la dermatologie esthetique |
KR20020043557A (ko) * | 1999-08-13 | 2002-06-10 | 바이오폼 인크. | 조직 증대 물질 및 방법 |
WO2003007782A2 (en) * | 2001-06-29 | 2003-01-30 | Medgraft Microtech, Inc. | Biodegradable injectable implants and related methods of manufacture and use |
US20040235791A1 (en) * | 2002-01-25 | 2004-11-25 | Gruskin Elliott A. | Scar reduction |
US7131997B2 (en) * | 2002-03-29 | 2006-11-07 | Scimed Life Systems, Inc. | Tissue treatment |
JP4303445B2 (ja) * | 2002-05-17 | 2009-07-29 | 株式会社ブラザーエンタープライズ | 表示装置及びその表示装置を備えた遊技機 |
EP1765367A4 (en) * | 2004-06-15 | 2010-08-11 | Therapeutics Inc Encore | PHOSPHOLIPID COMPOSITIONS AND METHOD FOR THEIR PREPARATION AND USE |
CN100464791C (zh) * | 2005-07-11 | 2009-03-04 | 山东大学 | 一种可注射性软组织生物填充材料的制备方法 |
KR100759091B1 (ko) * | 2006-12-13 | 2007-09-17 | 조강선 | 피부 충전제 조성물 |
-
2006
- 2006-12-13 KR KR1020060126815A patent/KR100759091B1/ko active IP Right Grant
-
2007
- 2007-04-24 CN CNA2007100976358A patent/CN101199871A/zh active Pending
- 2007-11-02 US US12/095,885 patent/US20080279806A1/en not_active Abandoned
- 2007-11-02 WO PCT/KR2007/005507 patent/WO2008072839A1/en active Application Filing
- 2007-11-02 JP JP2009541209A patent/JP4532602B2/ja active Active
- 2007-11-02 TR TR2009/03626T patent/TR200903626T1/xx unknown
- 2007-11-02 MY MYPI20092406A patent/MY153641A/en unknown
- 2007-11-02 CN CN200780014523XA patent/CN101426451B/zh active Active
-
2009
- 2009-07-22 HK HK09106700.9A patent/HK1128611A1/xx unknown
Also Published As
Publication number | Publication date |
---|---|
KR100759091B1 (ko) | 2007-09-17 |
WO2008072839A1 (en) | 2008-06-19 |
CN101199871A (zh) | 2008-06-18 |
MY153641A (en) | 2015-03-13 |
JP2010512830A (ja) | 2010-04-30 |
US20080279806A1 (en) | 2008-11-13 |
CN101426451B (zh) | 2011-06-15 |
TR200903626T1 (tr) | 2009-10-21 |
HK1128611A1 (en) | 2009-11-06 |
CN101426451A (zh) | 2009-05-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4532602B2 (ja) | 皮膚充填剤組成物 | |
Gao et al. | A novel dual-adhesive and bioactive hydrogel activated by bioglass for wound healing | |
JP6913134B2 (ja) | 注射可能なシルクフィブロイン発泡体およびその使用 | |
CN101366978B (zh) | 可注射用的微粒组织充填材料及其制备方法 | |
JP6660469B2 (ja) | ヒアルロン酸誘導体およびdna分画物が含まれているヒアルロン酸注射用組成物およびその利用 | |
JP5642388B2 (ja) | 注射用ヒアルロン酸ゲル移植片混合物 | |
ES2647227T3 (es) | Método para reticular ácido hialurónico; método para preparar un hidrogel inyectable; hidrogel obtenido; uso del gel obtenido | |
KR101003331B1 (ko) | 피부 충전제 조성물 | |
CN107708675A (zh) | 假塑性微凝胶基质的组合物和试剂盒 | |
CN106117318A (zh) | 结合透明质酸的合成肽聚糖、制备和使用方法 | |
KR20090043973A (ko) | 피부 충전제 조성물 | |
JP2014510590A (ja) | フィラー製品および少なくとも1つの生体吸収性および生分解性シリカベースの材料を含む組成物 | |
BR112021011574A2 (pt) | Ácido hialurônico modificado por aldeído, método para preparar o mesmo e aplicações do mesmo | |
WO2020242420A1 (en) | A hybrid hydrogel used as a dermal filler and its production method | |
CN100356990C (zh) | 基于陶瓷的用来注入软组织的可注射植入物 | |
CN101347638A (zh) | 可注射用的组织修补材料及其制备方法 | |
CN108853595A (zh) | 一种磷酸钙修饰的交联玻尿酸微球的制备方法 | |
KR20090068088A (ko) | 새로운 피부 충전제 조성물 | |
Gold | Development of an Injectable, Cellulose-Based Hydrogel System for Soft Tissue Reconstruction | |
Goldberg | BIOALCAMID® | |
Breithaupt et al. | COS DERM | |
MLF et al. | Clinical evaluation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20100301 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20100302 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20100309 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20100518 |
|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20100610 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 4532602 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130618 Year of fee payment: 3 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |